Skip to main content
. 2010 Apr 14;16(14):1776–1781. doi: 10.3748/wjg.v16.i14.1776

Figure 1.

Figure 1

Relapse rate at 1 year (A) and 2 years (B). Group A: Treated with mesalamine after induction therapy with oral prednisolone; Group B: Treated with azathioprine after induction therapy with oral prednisolone; Group C: Treated with infliximab and azathioprine for induction and maintenance therapy.